{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:12:36Z","timestamp":1792872756685,"version":"4.5.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R15AR062883"],"award-info":[{"award-number":["R15AR062883"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Acetylon Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We have demonstrated previously that histone deacetylase (HDAC6) expression is increased in animal models of systemic lupus erythematosus (SLE) and that inhibition of HDAC6 decreased disease. In our current studies, we tested if an orally active selective HDAC6 inhibitor would decrease disease pathogenesis in a lupus mouse model with established early disease. Additionally, we sought to delineate the cellular and molecular mechanism(s) of action of a selective HDAC6 inhibitor in SLE. We treated 20-week-old (early-disease) New Zealand Black (NZB)\/White F1 female mice with two different doses of the selective HDAC6 inhibitor (ACY-738) for 5 weeks. As the mice aged, we determined autoantibody production and cytokine levels by enzyme-linked immunosorbent assay (ELISA) and renal function by measuring proteinuria. At the termination of the study, we performed a comprehensive analysis on B cells, T cells and innate immune cells using flow cytometry and examined renal tissue for immune-mediated pathogenesis using immunohistochemistry and immunofluorescence. Our results showed a reduced germinal centre B cell response, decreased T follicular helper cells and diminished interferon (IFN)-\u03b3 production from T helper cells in splenic tissue. Additionally, we found the IFN-\u03b1-producing ability of plasmacytoid dendritic cells was decreased along with immunoglobulin isotype switching and the generation of pathogenic autoantibodies. Renal tissue showed decreased immunoglobulin deposition and reduced inflammation as judged by glomerular and interstitial inflammation. Taken together, these studies show selective HDAC6 inhibition decreased several parameters of disease pathogenesis in lupus-prone mice. The decrease was due in part to inhibition of B cell development and response.<\/jats:p>","DOI":"10.1111\/cei.13046","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T14:42:44Z","timestamp":1504708964000},"page":"19-31","source":"Crossref","is-referenced-by-count":23,"title":["Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5979-7443","authenticated-orcid":false,"given":"J","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Vieson","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kazmierczak","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2809-5836","authenticated-orcid":false,"given":"X M","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Reilly","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA"},{"name":"Edward Via College of Osteopathic Medicine, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"2021120808313459700_cei13046-bib-0001","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0961203310389100","article-title":"IL-17-producing T cells in lupus nephritis","volume":"20","author":"Apostolidis","year":"2011","journal-title":"Lupus"},{"key":"2021120808313459700_cei13046-bib-0002","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.0800771","article-title":"B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus","volume":"182","author":"Nacionales","year":"2009","journal-title":"J Immunol"},{"key":"2021120808313459700_cei13046-bib-0003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00126839-200809030-00008","article-title":"Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator","volume":"9","year":"2008","journal-title":"Drugs R&D"},{"key":"2021120808313459700_cei13046-bib-0004","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4049\/jimmunol.177.1.383","article-title":"Characterization of human complement receptor type 2 (CR2\/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus","volume":"177","author":"Asokan","year":"2006","journal-title":"J Immunol"},{"key":"2021120808313459700_cei13046-bib-0005","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.4049\/jimmunol.174.5.2499","article-title":"IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black \u00d7 New Zealand White) F1 but not in BALB\/c mice","volume":"174","author":"Mathian","year":"2005","journal-title":"J Immunol"},{"key":"2021120808313459700_cei13046-bib-0006","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J Exp Med"},{"key":"2021120808313459700_cei13046-bib-0007","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1084\/jem.20132522","article-title":"Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"211","author":"Sisirak","year":"2014","journal-title":"J Exp Med"},{"key":"2021120808313459700_cei13046-bib-0008","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J Exp Med"},{"key":"2021120808313459700_cei13046-bib-0009","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021120808313459700_cei13046-bib-0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3892\/br.2015.556","article-title":"Epigenetics in systemic lupus erythematosus","volume":"4","author":"Xiao","year":"2016","journal-title":"Biomed Rep"},{"key":"2021120808313459700_cei13046-bib-0011","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"2021120808313459700_cei13046-bib-0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"key":"2021120808313459700_cei13046-bib-0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.it.2011.04.001","article-title":"Histone deacetylases as regulators of inflammation and immunity","volume":"32","author":"Shakespear","year":"2011","journal-title":"Trends Immunol"},{"key":"2021120808313459700_cei13046-bib-0014","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry","volume":"22","author":"Alchi","year":"2012","journal-title":"Lupus"},{"key":"2021120808313459700_cei13046-bib-0015","first-page":"11885","article-title":"Treatment with a selective histone deacetylase 6 inhibitor decreases lupus nephritis in NZB\/W mice","author":"Vieson","year":"2017","journal-title":"Histol Histopathol"},{"key":"2021120808313459700_cei13046-bib-0016","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2015.11.007","article-title":"Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB\/W mice","volume":"162","author":"Regna","year":"2016","journal-title":"Clin Immunol"},{"key":"2021120808313459700_cei13046-bib-0017","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.intimp.2015.10.006","article-title":"HDAC expression and activity is upregulated in diseased lupus-prone mice","volume":"29","author":"Regna","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"2021120808313459700_cei13046-bib-0018","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Liu","year":"2012","journal-title":"Nat Med"},{"key":"2021120808313459700_cei13046-bib-0019","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2021120808313459700_cei13046-bib-0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1191\/0961203303lu334oa","article-title":"Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus","volume":"12","author":"Arbuckle","year":"2003","journal-title":"Lupus"},{"key":"2021120808313459700_cei13046-bib-0021","doi-asserted-by":"crossref","first-page":"e0118176","DOI":"10.1371\/journal.pone.0118176","article-title":"Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL\/lpr mouse model","volume":"10","author":"Liao","year":"2015","journal-title":"PLOS ONE"},{"key":"2021120808313459700_cei13046-bib-0022","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2021120808313459700_cei13046-bib-0023","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/eji.201343498","article-title":"Sca-1 expression defines developmental stages of mouse pDCs that show functional heterogeneity in the endosomal but not lysosomal TLR9 response","volume":"43","author":"Niederquell","year":"2013","journal-title":"Eur J Immunol"},{"key":"2021120808313459700_cei13046-bib-0024","doi-asserted-by":"crossref","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","article-title":"Interferome v2.0: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2021120808313459700_cei13046-bib-0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"2021120808313459700_cei13046-bib-0026","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"key":"2021120808313459700_cei13046-bib-0027","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","article-title":"TLR9\/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE","volume":"203","author":"Ehlers","year":"2006","journal-title":"J Exp Med"},{"key":"2021120808313459700_cei13046-bib-0028","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"2021120808313459700_cei13046-bib-0029","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.179.1.305","article-title":"Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB\/W F1 mice","volume":"179","author":"Ishida","year":"1994","journal-title":"J Exp Med"},{"key":"2021120808313459700_cei13046-bib-0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/eji.1830250103","article-title":"Experimental therapy of systemic lupus erythematosus: the treatment of NZB\/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis","volume":"25","author":"Ozmen","year":"1995","journal-title":"Eur J Immunol"},{"key":"2021120808313459700_cei13046-bib-0031","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2040620712466864","article-title":"Epigenetic therapy of hematological malignancies: where are we now?","volume":"4","author":"Popovic","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"2021120808313459700_cei13046-bib-0032","first-page":"467","article-title":"Drug repositioning strategies for the identification of novel therapies for rheumatic autoimmune inflammatory diseases","volume":"43","author":"Grammer","year":"2017","journal-title":"Clin North Am"},{"key":"2021120808313459700_cei13046-bib-0033","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S1470-2045(13)70425-X","article-title":"Histone deacetylase inhibitors in multiple myeloma","volume":"14","author":"Pratt","year":"2013","journal-title":"Lancet Oncol"},{"key":"2021120808313459700_cei13046-bib-0034","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.det.2015.05.010","article-title":"Histone deacetylase inhibitors for cutaneous T-cell lymphoma","volume":"33","author":"Duvic","year":"2015","journal-title":"Dermatol Clin"},{"key":"2021120808313459700_cei13046-bib-0035","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1038\/ncomms7838","article-title":"Manipulation of B-cell responses with histone deacetylase inhibitors","volume":"6","author":"Waibel","year":"2015","journal-title":"Nat Commun"},{"key":"2021120808313459700_cei13046-bib-0036","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J Clin Invest"},{"key":"2021120808313459700_cei13046-bib-0037","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.4049\/jimmunol.173.6.4171","article-title":"Modulation of renal disease in MRL\/lpr mice by suberoylanilide hydroxamic acid","volume":"173","author":"Reilly","year":"2004","journal-title":"J Immunol"},{"key":"2021120808313459700_cei13046-bib-0038","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000368585","article-title":"Rituximab in systemic lupus erythematosus and lupus nephritis","volume":"128","author":"Beckwith","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"2021120808313459700_cei13046-bib-0039","doi-asserted-by":"crossref","first-page":"48246","DOI":"10.1074\/jbc.M408583200","article-title":"Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention","volume":"279","author":"Bertos","year":"2004","journal-title":"J Biol Chem"},{"key":"2021120808313459700_cei13046-bib-0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"2021120808313459700_cei13046-bib-0041","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/febs.12079","article-title":"Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes","volume":"280","author":"Li","year":"2013","journal-title":"FEBS J"},{"key":"2021120808313459700_cei13046-bib-0042","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/ard.2007.083162","article-title":"Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus","volume":"67","author":"Albert","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2021120808313459700_cei13046-bib-0043","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1479-5876-5-46","article-title":"Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis","volume":"5","author":"Korthals","year":"2007","journal-title":"J Trans Med"},{"key":"2021120808313459700_cei13046-bib-0044","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/icb.2012.7","article-title":"Modulation of T-cell function by type I interferon","volume":"90","author":"Tough","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"2021120808313459700_cei13046-bib-0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2009.07.005","article-title":"Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells","volume":"31","author":"Cucak","year":"2009","journal-title":"Immunity"},{"key":"2021120808313459700_cei13046-bib-0046","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4049\/jimmunol.0801607","article-title":"Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen","volume":"183","author":"Gallagher","year":"2009","journal-title":"J Immunol"},{"key":"2021120808313459700_cei13046-bib-0047","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/icb.2012.10","article-title":"Role of type I interferons in the activation of autoreactive B cells","volume":"90","author":"Kiefer","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"2021120808313459700_cei13046-bib-0048","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/eji.201040649","article-title":"Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB\u00d7NZW)F1 mice but not in BALB\/c mice","volume":"41","author":"Mathian","year":"2011","journal-title":"Eur J Immunol"},{"key":"2021120808313459700_cei13046-bib-0049","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clim.2012.09.009","article-title":"Small molecules in the treatment of systemic lupus erythematosus","volume":"148","author":"Markopoulou","year":"2013","journal-title":"Clin Immunol"},{"key":"2021120808313459700_cei13046-bib-0050","doi-asserted-by":"crossref","first-page":"e54001","DOI":"10.1371\/journal.pone.0054001","article-title":"Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling","volume":"8","author":"Liu","year":"2013","journal-title":"PLOS ONE"},{"key":"2021120808313459700_cei13046-bib-0051","doi-asserted-by":"crossref","first-page":"F996","DOI":"10.1152\/ajprenal.00282.2009","article-title":"Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy","volume":"297","author":"Pang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2021120808313459700_cei13046-bib-0052","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaut.2008.04.020","article-title":"The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB\/W F1 mice","volume":"31","author":"Reilly","year":"2008","journal-title":"J Autoimmun"},{"key":"2021120808313459700_cei13046-bib-0053","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.juro.2013.06.110","article-title":"HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-beta mediated renal fibrosis in obstructive uropathy","volume":"191","author":"Manson","year":"2014","journal-title":"J Urol"},{"key":"2021120808313459700_cei13046-bib-0054","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1681\/ASN.2007091040","article-title":"Epigenetic regulation of BMP7 in the regenerative response to ischemia","volume":"19","author":"Marumo","year":"2008","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/191\/1\/19\/41645215\/cei13046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/191\/1\/19\/41645215\/cei13046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T19:06:11Z","timestamp":1719428771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/191\/1\/19\/6412323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,10,16]]},"published-print":{"date-parts":[[2017,12,8]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13046","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,10,16]]}}}